ClinicalTrials.gov
ClinicalTrials.gov Menu

Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01103375
Recruitment Status : Terminated (Slow accrual)
First Posted : April 14, 2010
Last Update Posted : May 30, 2017
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Wake Forest University Health Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2013
  Actual Study Completion Date : March 2013